Awareness campaign from Definium tells mental healthcare providers disregulated brain circuitry may contribute to chronic ...
Anxiety disorders are a group of disorders that share symptoms like excessive fear and heightened stress (American Psychological Association [APA], 2022). It is important to note that fear and anxiety ...
Definium Therapeutics, Inc. ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new ...
The month of May is Mental Health Awareness Month, and an appropriate time to shine a spotlight on a mental health disorder that has been underserved and underacknowledged for too long. On May 4, ...
Verywell Health on MSN
Generalized anxiety disorder (GAD) symptoms and treatment
Symptoms of GAD include fatigue, difficulty sleeping, and trouble concentrating. GAD affects 6.8 million adults in the United ...
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain ...
New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States The annual ...
Objective The aim of the study was to assess the psychometric properties of the Afaan Oromoo version of Generalised Anxiety ...
NEW YORK--(BUSINESS WIRE)--Researchers from Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results